More Than Half A Million Baxter Sigma Spectrum Infusion Pumps Recalled Over Corrosion, Cleaning Problems

Baxter Healthcare recalled more than 500,000 infusion pumps, following thousands of complaints suggesting the tubing may corrode, increasing the risk of an infusion delay or interruption in treatment.

The FDA announced the Baxter Sigma Spectrum Infusion Pump recall on December 1, indicating the manufacturer received at least 17,493 reports of the devices accumulating fluid residue or corroding, including at least 16 serious injuries. The action has been categorized as a class I medical device recall, meaning continued use may cause serious injuries or death.

The recalled infusion pumps are used in the hospital or healthcare settings to deliver controlled amounts of fluids, such as pharmaceutical drugs, blood, and blood products through tubing into a patient’s vein or other cleared routes of administration.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

According to the recall announcement, due to cleaning problems, the tubing may begin to accumulate fluid residue or become corroded which could cause a blockage or delay in critical fluid delivery.

Officials warn healthcare professionals that, in the event the corrosion or fluid buildup occurs while the device is being used on battery power, the pump could unexpectedly shut down without signaling an alarm, causing a delay or complete interruption in treatment.

The recall includes Baxter SIGMA Spectrum Infusion Pump with Master Drug Library with product codes 35700ABB and 35700BAX, Baxter SIGMA Spectrum Infusion Pump with Master Drug Library with product code 35700BAX2 and Spectrum IQ Infusion System with Dose IQ Safety Software with product code 357009.

The devices were manufactured by Baxter International Healthcare Company of Deerfield, Illinois. They were distributed to hospitals and healthcare facilities nationwide from July 1, 2008 to July 14, 2020. Officials indicate approximately 553,443 units were sold throughout the U.S.

Baxter Healthcare sent an Urgent Device Correction to all known customers on August 28, with instructions on how to properly clean the infusion pumps, and to inspect all inventory to check the electrical pins on the pump rear case and the battery electrical contacts for residue buildup or corrosion. The manufacturer further instructed customers to contact Baxter for service if residue build-up is discovered.

Healthcare professionals are being instructed to keep the devices plugged in to AC power when possible to prevent battery depletion and to make sure a backup device is readily available when infusing critical medications that could cause serious injury or death if interrupted.

Customers with additional questions or concerns regarding the recall are encouraged to contact Baxter Technical Assistance at 800-356-3454. Any adverse reactions or quality problems while using the devices should be submitted through the FDA Safety Information and Adverse Event Reporting Program.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted today)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted yesterday)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.

Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children
Master Baby Food Lawsuit Filed in MDL Outlines How Toxic Metals Caused Autism, ADHD in Children (Posted 4 days ago)

Plaintiffs have submitted a baby food lawsuit Master Complaint that is expected to streamline the filing of lawsuits alleging that toxic heavy metals in Beech-Nut, Gerber, Hain and Nurture products caused ADHD, autism and other developmental disorders.